Amrutanjan Health Care Limited (NSE:AMRUTANJAN)

Market Cap	17.30B
Revenue (ttm)	4.44B
Net Income (ttm)	493.16M
Shares Out	n/a
EPS (ttm)	17.04
PE Ratio	35.07
Forward PE	n/a
Dividend	4.60 (0.77%)
Ex-Dividend Date	Feb 18, 2025

Volume	15,972
Average Volume	14,759
Open	601.85
Previous Close	597.75
Day's Range	593.45 - 607.60
52-Week Range	586.40 - 862.60
Beta	0.79
RSI	32.20
Earnings Date	Feb 7, 2025

About Amrutanjan Health Care

Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products comprising pain balms and roll-ons; and back pain roll-ons, stick-on patch, body pain gels, and joint muscle sprays. The company offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints. It also provides sanitary napkins for women. In addition, the company offers corn c...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1893
• Employees: 634
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AMRUTANJAN

Financial Performance

In 2023, Amrutanjan Health Care's revenue was 4.21 billion, an increase of 10.96% compared to the previous year's 3.80 billion. Earnings were 449.73 million, an increase of 12.90%.